InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Szekeres David Leslie, Chief Executive Officer. Officer active across 1 companies, notably Heron Therapeutics, INC.. In total, 7 disclosures have been logged. The latest transaction was filed on 30 April 2021 — J. Regulator: SEC (Form 4). All data is free.
Declarations7 total
1,250 shares
Common Stock
SEC:0001209191-22-024523:0·
1,250 shares
Common Stock
SEC:0001209191-22-003364·
1,250 shares
Common Stock
SEC:0001209191-22-003364:0·
1,250 shares
Common Stock
SEC:0001209191-21-060553·
1,250 shares
Common Stock
SEC:0001209191-21-060553:0·
€17,5341,530 shares@ €11.45990.0072% mcap100.0% of flow
Common Stock
SEC:0001209191-21-046791·
€17,5341,530 shares@ €11.45990.0072% mcap50.0% of flow
Common Stock
SEC:0001209191-21-046791:0·
7 of 7 declarations
About Szekeres David Leslie
David Leslie Szekeres is the Chief Operating Officer at HERON THERAPEUTICS, INC. He oversees the company's operations and implements strategies to enhance efficiency. His expertise in the pharmaceutical sector is essential for the company's growth.
